Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-17-011455
Filing Date
2017-11-13
Accepted
2017-11-13 16:07:43
Documents
1
Period of Report
2017-11-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_151060724600611.html 4  
1 FORM 4 wf-form4_151060724600611.xml 4 3924
  Complete submission text file 0001628280-17-011455.txt   5611
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Issuer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 233 EAST REDWOOD ST BALTIMORE MD 21202
Business Address
Poliakoff Abba David (Reporting) CIK: 0001423066 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-11504 | Film No.: 171195893